Judith A.F. Huirne

ORCID: 0000-0002-8248-2677 · 47 papers in corpus
2022
PloS one ·doi:10.1371/journal.pone.0269478

BackgroundFibroids have been identified as a possible risk factor for preterm birth, however, the magnitude of this risk is unclear. Our objective was to determine the risk of total, spontaneous, and medically indicated preterm birth in wom…

2021
JMIR research protocols ·doi:10.2196/29467

BackgroundMagnetic resonance image-guided high-intensity-focused ultrasound (MR-HIFU) is a rather new, noninvasive option for the treatment of uterine fibroids. It is safe, effective, and has a very short recovery time. However, a lack of p…

review 2021
Ultrasonic imaging ·doi:10.1177/01617346211017462

Uterine disorders are often presented with overlapping symptoms. The microvasculature holds specific information important for diagnosing uterine disorders. Conventional sonography is an established diagnostic technique in gynecology, but i…

review 2021
·doi:10.1016/j.jmig.2021.09.285
2020
JMIR public health and surveillance ·doi:10.2196/18928

BackgroundThe current coronavirus disease (COVID-19) pandemic is holding the world in its grip. Epidemiologists have shown that the mortality risks are higher when the health care system is subjected to pressure from COVID-19. It is therefo…

2019
Journal of medical Internet research ·doi:10.2196/jmir.9938

BackgroundSupport for guiding and monitoring postoperative recovery and resumption of activities is usually not provided to patients after discharge from the hospital. Therefore, a perioperative electronic health (eHealth) intervention ("ik…

review 2019
Human Reproduction Update ·doi:10.1093/humupd/dmz024

BACKGROUND: Adenomyosis commonly occurs with abnormal uterine bleeding (AUB) and is associated with subfertility and a higher miscarriage rate. Recent evidence showed abnormal vascularization in the endometrium in patients with adenomyosis,…

article 2018
Ultrasound in medicine & biology ·doi:10.1016/j.ultrasmedbio.2018.03.027

The aims of this prospective diagnostic evaluation study were (i) to estimate the inter-observer agreement and reproducibility of real-time sonoelastography and real-time gray-scale ultrasound in the measurement of uterine and fibroid volum…

editorial 2018
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology ·doi:10.1002/uog.19096

In 2015, the international Morphological Uterus Sonographic Assessment (MUSA) group published a consensus on which terminology to use when describing myometrial lesions seen on ultrasonography1. The use of MUSA terminology to describe ultra…

article 2018
JMIR research protocols ·doi:10.2196/resprot.8512

BACKGROUND: Adenomyosis is a benign uterine disease characterized by invasion of endometrium into the myometrium resulting in heavy menstrual bleeding and pain (dysmenorrhea). Hysterectomy is established as the final treatment option when c…

review 2017
The Cochrane database of systematic reviews ·doi:10.1002/14651858.cd011126.pub2

BACKGROUND: Focal abnormalities most commonly acquired within the uterine cavity include endometrial polyps (arising from the endometrium) and submucous fibroids (arising from the myometrium). These benign abnormalities can cause several pr…

review 2017
Journal of vascular and interventional radiology : JVIR ·doi:10.1016/j.jvir.2017.07.034

The effect of uterine artery embolization (UAE) on symptomatic adenomyosis was evaluated in a systematic review and meta-analysis. Four groups were evaluated: short-term ( 12 months) pure adenomyosis, and long-term combined adenomyosis. Imp…

article 2017
·doi:10.2196/jrp.v7i3.8512

Background: Adenomyosis is a benign uterine disease characterized by invasion of endometrium into the myometrium resulting in heavy menstrual bleeding and pain (dysmenorrhea). Hysterectomy is established as the final treatment option when c…

preprint 2017
·doi:10.2196/preprints.8512

BACKGROUND Adenomyosis is a benign uterine disease characterized by invasion of endometrium into the myometrium resulting in heavy menstrual bleeding and pain (dysmenorrhea). Hysterectomy is established as the final treatment option when c…

2016
JMIR research protocols ·doi:10.2196/resprot.6580

BackgroundDue to the strong reduction in the length of hospital stays in the last decade, the period of in-hospital postoperative care is limited. After discharge from the hospital, guidance and monitoring on recovery and resumption of (wor…

article 2015
·doi:10.1002/uog.15200

We evaluated the additional value of elastography in addition to conventional gray-scale ultrasound, for diagnosing uterine fibroids and adenomyosis. We performed a prospective cohort study with MRI as a reference test. Random stored cinelo…

article 2015
·doi:10.1093/humrep/dev240

Caesarean section (CS) results in the occurrence of the phenomenon 'niche'. A 'niche' describes the presence of a hypoechoic area within the myometrium of the lower uterine segment, reflecting a discontinuation of the myometrium at the site…

article 2014
·doi:10.1002/uog.13548

The aim of this study was to test the reproducibility of elastography in the diagnosis of uterine abnormalities. We performed a prospective case control study with MRI as a reference test. Twenty premenopausal woman with the diagnosis intra…

article 2013
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology ·doi:10.1002/uog.12519

OBJECTIVES: Sonoelastography is an ultrasound-imaging technique that measures tissue strain. The aim of this study was to define, in a systematic manner, specific sonoelastographic characteristics of the myometrium, fibroids and adenomyosis…

article 2013
·doi:10.1002/uog.12913

Sono-elastography is an imaging technique added to sonography, measuring tissue strain. The aim of this study is to systematically define specific sono-elastographic characteristics of the myometrium, fibroids and adenomyosis and evaluate t…

book-chapter 2012
·doi:10.3109/9781841849737.040
book-chapter 2012
·doi:10.3109/9781841849737-13

GnRH is produced and released from a group of loosely connected neurons located in the medial basal hypothalamus, primarily within the arcuate nucleus, and in the preoptic area of the ventral hypothalamus. It is synthesized in the cell body…